U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT06834230) titled 'Effect of Dotinurad in Hyperuricemia With Hypertension: a Randomized Study With Febuxostat' on Jan. 30.
Brief Summary: The effect of dotinurad on CAVI (cardio-ankle vascular index) will be compared with that of febuxostat in patients with hyperuricemia complicated by hypertension.
Study Start Date: March 03
Study Type: INTERVENTIONAL
Condition:
Hyperuricemia or Gout
Hypertension
Intervention:
DRUG: Dotinurad
Start at 0.5 mg once daily, and then referring to the attached document, gradually increase the dose to the maintenance dose (2 mg once daily).
DRUG: Febuxostat
Start at 10 mg once daily, and then referring to the attac...